SCHEMBL10458342

SCHEMBL10458342

CC(C)ON(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28462716 0.96
SCHEMBL9463592 0.96
SCHEMBL29261029 0.70
SCHEMBL10187351 0.69
SCHEMBL9579841 0.69
SCHEMBL25082459 0.69
SCHEMBL5502103 0.69
SCHEMBL13103927 0.65
SCHEMBL13966600 0.65
SCHEMBL19821999 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104226123-A Preparation method of high-flux and anti-pollution reverse osmosis membrane and application of membrane BEIJING ORIGIN WATER FILM TECHNOLOGY CO LTD 2014-12-24 CN claimed
CN-1731972-A Treatment of skin wounds with polyenylphosphatidylcholine and alkanolamine PERRICONE NICHOLAS V (US) 2006-02-08 CN claimed
CN-1188119-C Method of reducing appearance of black colour at lower part of eye JOHNSON & JOHNSON CONSUMER (US) 2005-02-09 CN claimed
CN-1365662-A Method of reducing appearance of black colour at lower part of eye JOHNSON & JOHNSON CONSUMER (US) 2002-08-28 CN claimed
CN-1364454-A Method for impoving skin clean JOHNSON & JOHNSON CONSUMER (US) 2002-08-21 CN claimed
JP-1282202-A None JP disclosed
CN-115703722-B Preparation method of N, N-dimethyl trifluoromethyl sulfonamide 江苏国泰超威新材料有限公司 2024-06-25 CN disclosed
CN-109438666-A Low temperature resistant, anti-ballistic materials and its preparation method and application 湖南御邦华安新材料科技有限公司 2019-03-08 CN disclosed
EP-2770977-B1 NOVEL DOSAGE FORM NEUROVIVE PHARMACEUTICAL AB (SE) 2017-07-12 EP disclosed
US-9504728-B2 Dosage form NEUROVIVE PHARMACEUTICAL AB (SE) 2016-11-29 US disclosed
US-9119853-B2 Sanglifehrin based compounds NEUROVIVE PHARMACEUTICAL AB (SE) 2015-09-01 US disclosed
CN-103120648-B Oral isoprinosine preparation and preparation method thereof BEIJING SE PHARMACEUTICAL CO LTD 2015-02-11 CN disclosed
WO-2013061052-A1 NOVEL DOSAGE FORM BIOTICA TECHNOLOGY LIMITED (GB) 2013-05-02 WO disclosed
CN-1731972-A Treatment of skin wounds with polyenylphosphatidylcholine and alkanolamine PERRICONE NICHOLAS V (US) 2006-02-08 CN disclosed
CN-1188119-C Method of reducing appearance of black colour at lower part of eye JOHNSON & JOHNSON CONSUMER (US) 2005-02-09 CN disclosed
CN-1397270-A Skin nursing care JOHNSON & JOHNSON CONSUMER (US) 2003-02-19 CN disclosed
CN-1365662-A Method of reducing appearance of black colour at lower part of eye JOHNSON & JOHNSON CONSUMER (US) 2002-08-28 CN disclosed
CN-1364454-A Method for impoving skin clean JOHNSON & JOHNSON CONSUMER (US) 2002-08-21 CN disclosed
US-4948812-A TREATMENT OF CARDIOVASCULAR DISORDERS; TACHYCARDIA; ANTIARRHYTHMIA AND HYPOTENSIVE AGENTS BOEHRINGER INGELHEIM KG (DE) 1990-08-14 US disclosed
JP-H01282202-A TERTIARY AMINOALKYL-HYDROXYALKYL ETHERS OF POLYGALACTOMANNANS HI TEK POLYMERS INC 1989-11-14 JP disclosed